RHOA and ovarian cancer: Indeed, in prior studies Zhang and Jiang described that RhoA inhibits the hypoxia-induced apoptosis in chondrocytes [63] and Khaider and colleagues demonstrated that the inhibition of BID expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells [64].